Join us for an enriching session filled with expertise, collaboration, and practical solutions featuring esteemed speakers and renowned hematologists, Dr. Meera. V, Dr. T.K. Dolai and Dr. Radhika KK. Takeda proudly presents this webinar to underscore the global initiative aimed at raising awareness and providing support for individuals living with bleeding disorders such as hemophilia. Together, our distinguished speakers will impart invaluable insights and strategies for effectively managing inhibitors in surgical settings for patients with Congenital Hemophilia with Inhibitors (CHaWI). 

Inhibitor management in CHaWI patients undergoing surgery

Head of Department of Clinical Hematology, Bangalore Medical College and Research Institute, Bangalore

Haemophilia care is evolving rapidly, with the focus extending beyond simply preventing and treating bleeding episodes to improving long-term outcomes and quality of life. This masterclass will take clinicians through the complete care pathway from recognising clinical clues and identifying patients who may have haemophilia to diagnosis, referral, treatment, monitoring and long-term management. It will explore the evolving treatment landscape, including the role and challenges of factor replacement therapy and the emergence of non-factor therapies. The session will also take a deeper look at non-factor prophylaxis in Haemophilia A and B without inhibitors, bringing together clinical evidence and real-world experience on bleed control and quality-of-life outcomes.

Haemophilia Masterclass 2026

This session takes a broader view of treatment success, exploring how newer non-factor approaches are changing haemophilia care and addressing outcomes beyond bleed control, including quality of life.

Why attend?
This session will help doctors understand the evolving approach to haemophilia treatment, beginning with the role of factor replacement and the practical challenges that can affect treatment outcomes, including inhibitor development, venous access, adherence and breakthrough bleeds. Attendees will also gain an understanding of non-factor therapies and their potential role in addressing some of these challenges while improving patient outcomes.

Dr. Meera Varadarajan

3

216

3.9k

4.5

Upcoming Sessions

Sessions Taken

191

4.5